Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1993 Jul;39:1635–1638.

Dyspnea in dying patients.

D H Hsu 1
PMCID: PMC2379564  PMID: 8348024

Abstract

Dyspnea is common in terminally ill patients and is often fairly difficult to control. If specific causes cannot be identified or treated, general measures to relieve symptoms should be used. Nondrug measures (eg, discussion and explanation with the patient) and drug measures (eg, morphine) can be used to control the dyspnea, although side effects, such as sedation, can be problematic.

Full text

PDF
1635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altose M. D. Assessment and management of breathlessness. Chest. 1985 Aug;88(2 Suppl):77S–83S. doi: 10.1378/chest.88.2_supplement.77s. [DOI] [PubMed] [Google Scholar]
  2. Bruera E., Macmillan K., Pither J., MacDonald R. N. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990 Dec;5(6):341–344. doi: 10.1016/0885-3924(90)90027-h. [DOI] [PubMed] [Google Scholar]
  3. Cohen M. H., Anderson A. J., Krasnow S. H., Spagnolo S. V., Citron M. L., Payne M., Fossieck B. E., Jr Continuous intravenous infusion of morphine for severe dyspnea. South Med J. 1991 Feb;84(2):229–234. doi: 10.1097/00007611-199102000-00019. [DOI] [PubMed] [Google Scholar]
  4. Coyle N., Adelhardt J., Foley K. M., Portenoy R. K. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990 Apr;5(2):83–93. doi: 10.1016/s0885-3924(05)80021-1. [DOI] [PubMed] [Google Scholar]
  5. Fainsinger R., Miller M. J., Bruera E., Hanson J., Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991 Spring;7(1):5–11. [PubMed] [Google Scholar]
  6. Henteleff P. D. Dyspnea management: "to take into the air my quiet breath". J Palliat Care. 1989 Dec;5(4):52–54. [PubMed] [Google Scholar]
  7. Higginson I., McCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med. 1989 May;82(5):264–267. doi: 10.1177/014107688908200507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Reuben D. B., Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986 Feb;89(2):234–236. doi: 10.1378/chest.89.2.234. [DOI] [PubMed] [Google Scholar]
  9. Ventafridda V., Ripamonti C., De Conno F., Tamburini M., Cassileth B. R. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care. 1990 Autumn;6(3):7–11. [PubMed] [Google Scholar]
  10. Wasserman K., Casaburi R. Dyspnea: physiological and pathophysiological mechanisms. Annu Rev Med. 1988;39:503–515. doi: 10.1146/annurev.me.39.020188.002443. [DOI] [PubMed] [Google Scholar]
  11. Woodcock A. A., Gross E. R., Geddes D. M. Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) 1981 Aug 1;283(6287):343–346. doi: 10.1136/bmj.283.6287.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Woodcock A. A., Gross E. R., Gellert A., Shah S., Johnson M., Geddes D. M. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981 Dec 31;305(27):1611–1616. doi: 10.1056/NEJM198112313052703. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES